Effects of angiotensin II type 1 receptor antagonist on electrical and structural remodeling in atrial fibrillation.

[1]  S. Nattel,et al.  Effects of inhibiting Na(+)/H(+)-exchange or angiotensin converting enzyme on atrial tachycardia-induced remodeling. , 2002, Cardiovascular research.

[2]  S. Nattel,et al.  Enalapril effects on atrial remodeling and atrial fibrillation in experimental congestive heart failure. , 2002, Cardiovascular research.

[3]  S. Goodacre,et al.  Atrial arrhythmias , 2002, BMJ : British Medical Journal.

[4]  H. Heidbüchel,et al.  Different Patterns of Angiotensin II and Atrial Natriuretic Peptide Secretion in a Sheep Model of Atrial Fibrillation , 2001, Journal of cardiovascular electrophysiology.

[5]  S. Nattel,et al.  Effects of Angiotensin-Converting Enzyme Inhibition on the Development of the Atrial Fibrillation Substrate in Dogs With Ventricular Tachypacing–Induced Congestive Heart Failure , 2001, Circulation.

[6]  J M de Bakker,et al.  Increased dispersion and shortened refractoriness caused by verapamil in chronic atrial fibrillation. , 2001, Journal of the American College of Cardiology.

[7]  S. Nattel,et al.  Differential efficacy of L- and T-type calcium channel blockers in preventing tachycardia-induced atrial remodeling in dogs. , 2001, Cardiovascular research.

[8]  M. Ihara,et al.  High Cardiac Angiotensin-II-Forming Activity in Infarcted and Non-Infarcted Human Myocardium , 2001, Cardiology.

[9]  K. Wasmer,et al.  Effects of Digoxin on Acute, Atrial Fibrillation–Induced Changes in Atrial Refractoriness , 2000, Circulation.

[10]  D. Haines,et al.  Electrical, Morphological, and Ultrastructural Remodeling and Reverse Remodeling in a Canine Model of Chronic Atrial Fibrillation , 2000, Circulation.

[11]  A. Goette,et al.  Regulation of angiotensin II receptor subtypes during atrial fibrillation in humans. , 2000, Circulation.

[12]  K. Arakawa,et al.  Angiotensin II antagonist prevents electrical remodeling in atrial fibrillation. , 2000, Circulation.

[13]  A. Goette,et al.  Increased expression of extracellular signal-regulated kinase and angiotensin-converting enzyme in human atria during atrial fibrillation. , 2000, Journal of the American College of Cardiology.

[14]  S. A. Chen,et al.  Effect of verapamil on long-term tachycardia-induced atrial electrical remodeling. , 2000, Circulation.

[15]  S. Nattel,et al.  The T-type Ca(2+) channel blocker mibefradil prevents the development of a substrate for atrial fibrillation by tachycardia-induced atrial remodeling in dogs. , 1999, Circulation.

[16]  L. Køber,et al.  Trandolapril reduces the incidence of atrial fibrillation after acute myocardial infarction in patients with left ventricular dysfunction. , 1999, Circulation.

[17]  S Nattel,et al.  Promotion of atrial fibrillation by heart failure in dogs: atrial remodeling of a different sort. , 1999, Circulation.

[18]  Wen-Chung Yu,et al.  Effects of 17β‐Estradiol on Tachycardia‐Induced Changes of Atrial Refractoriness and Cisapride‐Induced Ventricular Arrhythmia , 1999, Journal of cardiovascular electrophysiology.

[19]  F. Weidemann,et al.  Chronic effects of early started angiotensin converting enzyme inhibition and angiotensin AT1-receptor subtype blockade in rats with myocardial infarction: role of bradykinin. , 1998, Cardiovascular research.

[20]  Y. Yazaki,et al.  Angiotensin II type 1a receptor is involved in the occurrence of reperfusion arrhythmias. , 1998, Circulation.

[21]  J Haaksma,et al.  Early recurrences of atrial fibrillation after electrical cardioversion: a result of fibrillation-induced electrical remodeling of the atria? , 1998, Journal of the American College of Cardiology.

[22]  M. Allessie,et al.  Electrical remodeling due to atrial fibrillation in chronically instrumented conscious goats: roles of neurohumoral changes, ischemia, atrial stretch, and high rate of electrical activation. , 1997, Circulation.

[23]  M. Allessie,et al.  Structural changes of atrial myocardium due to sustained atrial fibrillation in the goat. , 1997, Circulation.

[24]  M. Allessie,et al.  Effects of atrial dilatation on refractory period and vulnerability to atrial fibrillation in the isolated Langendorff-perfused rabbit heart. , 1997, Circulation.

[25]  F. Morady,et al.  Effect of verapamil and procainamide on atrial fibrillation-induced electrical remodeling in humans. , 1997, Circulation.

[26]  M. Allessie,et al.  Verapamil reduces tachycardia-induced electrical remodeling of the atria. , 1997, Circulation.

[27]  A. Goette,et al.  Electrical remodeling in atrial fibrillation. Time course and mechanisms. , 1996, Circulation.

[28]  Y. Mori,et al.  Mechanical stretch induces enhanced expression of angiotensin II receptor subtypes in neonatal rat cardiac myocytes. , 1996, Circulation research.

[29]  D. Zipes,et al.  Unequal Atrial Stretch in dogs Increases Dispersion of Refractoriness Conducive to developing Atrial Fibrillation , 1996, Journal of cardiovascular electrophysiology.

[30]  H. Crijns,et al.  Effects of lisinopril in patients with heart failure and chronic atrial fibrillation. , 1995, Journal of cardiac failure.

[31]  M. Allessie,et al.  Atrial fibrillation begets atrial fibrillation. A study in awake chronically instrumented goats. , 1995, Circulation.

[32]  S. Toumanidis,et al.  Atrial Pressure and Experimental Atrial Fibrillation , 1995, Pacing and clinical electrophysiology : PACE.

[33]  E. Fleck,et al.  Hemodynamic and Neurohormonal Effects of the Angiotensin II Antagonist Losartan in Patients With Congestive Heart Failure , 1993, Circulation.

[34]  K. Arakawa,et al.  Effects of Verapamil on Electrophysiological Properties in Paroxysmal Atrial Fibrillation , 1993, Pacing and clinical electrophysiology : PACE.

[35]  M. Shenasa,et al.  Effect of intravenous and oral calcium antagonists (diltiazem and verapamil) on sustenance of atrial fibrillation. , 1988, The American journal of cardiology.